Listed

ImmunityBio, Inc.

IBRXNasdaqCIK 1326110HealthcareFiscal year ends Dec 31

Reports and events: 180 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

ImmunityBio, Inc., Reports and events
FiledFormWhat it isAccession number
2024-08-1208:03 ET10-QQuarterly reportPeriod 2024-06-300001326110-24-000103
2024-07-1821:48 ET8-K1.01 Entry into a material agreement0001326110-24-000093
2024-06-1216:36 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001326110-24-000069
2024-05-0917:00 ET10-QQuarterly reportPeriod 2024-03-310001326110-24-000064
2024-04-2916:18 ETDEF 14AProxy statementPeriod 2024-06-110001326110-24-000054
2024-04-2306:17 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001326110-24-000040
2024-03-1916:31 ET10-KAnnual reportPeriod 2023-12-310001326110-24-000037
2024-02-2621:28 ET8-K5.02 Departure or appointment of officers or directors; 5.05 Item not in the standard list0001193125-24-044886
2024-01-0421:59 ETSC 13D/AOwnership report, active investor, amended0001193125-24-001705
2024-01-0206:08 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001326110-24-000003
2023-11-0921:28 ET10-QQuarterly reportPeriod 2023-09-300001326110-23-000147
2023-09-2116:25 ETSC 13D/AOwnership report, active investor, amended0001193125-23-239612
2023-09-1106:25 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001326110-23-000121
2023-09-0108:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001326110-23-000112
2023-08-1516:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001326110-23-000102
2023-08-0816:15 ET10-QQuarterly reportPeriod 2023-06-300001326110-23-000098
2023-07-2106:04 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-23-190800
2023-07-2016:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-190491
2023-06-1417:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001326110-23-000076
2023-05-2319:15 ETSC 13D/AOwnership report, active investor, amended0001193125-23-150724
2023-05-1106:47 ET10-QQuarterly reportPeriod 2023-03-310001326110-23-000064
2023-05-1106:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001326110-23-000063
2023-04-2816:24 ETDEF 14AProxy statement0001326110-23-000050
2023-03-3116:29 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001326110-23-000028
2023-03-2008:31 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001326110-23-000023
2023-03-0117:18 ET10-KAnnual reportPeriod 2022-12-310001326110-23-000018
2023-02-1509:20 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-23-039833
2023-02-1417:25 ET8-K2.02 Results of operations0001193125-23-039399
2023-02-1308:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001326110-23-000014
2022-12-1209:07 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-302356
2022-12-0720:28 ETSC 13D/AOwnership report, active investor, amended0001193125-22-299573
2022-12-0510:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001326110-22-000076
2022-11-1508:42 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-285314
2022-11-0920:52 ET10-QQuarterly reportPeriod 2022-09-300001326110-22-000074
2022-09-0216:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001326110-22-000064
2022-08-0816:45 ET10-QQuarterly reportPeriod 2022-06-300001326110-22-000058
2022-06-1416:59 ET8-K5.07 Shareholder vote results0001326110-22-000038
2022-05-1016:08 ET10-QQuarterly reportPeriod 2022-03-310001326110-22-000027
2022-04-2916:11 ETDEF 14AProxy statementPeriod 2022-06-140001193125-22-133671
2022-03-2517:23 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-085325
2022-03-0117:03 ET10-KAnnual reportPeriod 2021-12-310001326110-22-000011
2022-02-1509:00 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-042967
2022-01-1208:35 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-007333
2021-12-2009:07 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-361818
2021-11-1216:38 ET10-QQuarterly reportPeriod 2021-09-300001326110-21-000009
2021-09-2708:46 ET8-K1.01 Entry into a material agreement0001193125-21-283078
2021-09-1308:37 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-270970
2021-08-1316:16 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-246082
2021-08-1216:29 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-044008
2021-06-1507:11 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-190551

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.